Lupin Limited (NSE:LUPIN)
1,899.80
-2.60 (-0.14%)
Aug 29, 2025, 3:29 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 864.68 billion as of August 29, 2025. Its market cap has decreased by -9.62% in one year.
Market Cap
864.68B
Enterprise Value
890.17B
Revenue
233.76B
Ranking
n/a
PE Ratio
23.37
Stock Price
1,899.80
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 864.68B, an increase of 86,529.48%. That is a compound annual growth rate of 29.80%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 29, 2025 | 864.68B | -19.38% |
Dec 31, 2024 | 1,072.58B | 78.05% |
Dec 29, 2023 | 602.42B | 80.75% |
Dec 30, 2022 | 333.29B | -22.86% |
Dec 31, 2021 | 432.05B | -2.46% |
Dec 31, 2020 | 442.95B | 27.89% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,825.74B |
Divi's Laboratories | 1,627.72B |
Cipla | 1,283.84B |
Apollo Hospitals Enterprise | 1,094.20B |
Mankind Pharma | 1,020.09B |
Zydus Lifesciences | 987.17B |
Fortis Healthcare | 688.14B |
Alkem Laboratories | 634.11B |